Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-08-13
1999-03-16
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242041, 4241841, 530350, 536 231, A61K 39145, A61K 3900, C07K 100, C07H 2102
Patent
active
058826505
ABSTRACT:
This disclosure relates to methods and compositions for stimulating in an individual an influenza A virus protective response which is subtype cross-protective. Influenza A virus NS1 protein, or a T cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response.
REFERENCES:
patent: 4803072 (1989-02-01), Dalton et al.
Wraith, D.C., et al., "Purified Influenza Virus Nucleoprotein Protects Mice from Lethal Infection," J. Gen. Virol., 68:433-440 (1987).
Bennink, J.R., et al., "Anti-Influenza Virus Cytotoxic T Lymphocytes Recognize the Three Viral Polymerases and a Nonstructural Protein: Responsiveness to Individual Viral Antigens Is Major Histocompatibility Complex Controlled," J. Gen. Virol., 61:1098-1102 (1987).
Yamada, A., et al., "Influenza Virus Hemagglutinin-Specific Cytotoxic T Cell Response Induced by Polypeptide Produced in Escherichia coli," J. Exp. Med., 162:663-674 (1985).
Kuwano, K., et al., "Active Immunization Against Virus Infections Due to Antigenic Drift by Induction of Crossreactive Cytotoxic T Lymphocytes," J. Exp. Med., 169:1361-1371 (1989).
Kuwano, K., et al., "HA2 Subunit of Influenza A H1 and H2 Subtype Viruses Induces a Protective Cross-Reactive Cytotoxic T Lymphocyte Response," J. Immunol., 140:1264-1268 (1988).
Kuwano, K., et al., "Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone," Immunochemistry, 113:499 (1990). (From Chem. Abstracts, Abstract No. 130459C).
Kingsman, Genetic Engineering Chapter 12, Blackwell Scientific Publications (Oxford, GB), 1988.
Young, et al., "Efficient Expression of Influenza Virus NS1 . . . " PNAS 80:6105-6109 (1983).
Smith, G.L., et al., "Synthesis and Cellular Location of Ten Influenza Polypeptides Individually Expressed by Recombinant Vaccinia Viruses," Virology, 160:336-345 (1987).
Shaw, M.W., et al., "Immunologic Studies on the Influenza A Virus Nonstructural Protein NS.sub.1," J. Exp. Med., 156:243-254 (1982).
Kuwano, K., et al., "Cross-Reactive Protection against Influenza A Virus Infections by an NS1-Specific CTL Clone," Virology, 178:174-179 (1990).
Cossins, J., et al., "Precise Prediction of a K.sup.k -Restricted Cytotoxic T Cell Epitope in the NS1 Protein of Influenza Virus Using an MHC Allele-Specific Motif," Virology, 193:289-295 (1993).
Hackett, C.J., et al., "Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein," J. of General Virology, 73:1339-1343 (1992).
Bennink, J.R. and Yewdell, J.W., "Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles," J. Exp. Med., 168(5):1935-1939 (1988).
Bennink, et al, "Anti-Influenza Virus Cytotoxic T Lymphocytes . . . " J. Virol. 61(4):1098-1102, 1987.
Kuwano, et al, "Cross-Reactive Protection against Influenza A Virus . . . " Virology 178:174-179, 1990.
Smith Lynette F.
University of Massachusetts Medical Center
LandOfFree
Cross-reactive influenza A immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cross-reactive influenza A immunization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-reactive influenza A immunization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-814865